Previous 10 | Next 10 |
Ampio Pharmaceuticals ( AMPE +2.5% ) announces the completion of enrollment in a 10-subject Phase 1 study assessing IV Ampion in COVID-19 patients requiring supplemental oxygen. Final results should be available next week after the Safety Monitoring Committee and principal investigator...
ENGLEWOOD, Colo. , Sept. 4, 2020 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions announces the following: Enrollment...
Coronavirus Penny Stocks Continue to Garner Widespread Market Attention COVID-19 has reshaped our entire world in only a matter of a few months and countless penny stocks have benefited. Beginning in January, many leading biotech companies quickly embarked on a mission to create a vacc...
ENGLEWOOD, Colo. , Aug. 19, 2020 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, provides updates regarding the following clinical trials: ...
July 28, 2020 Palm Beach, FL – July 28, 2020 – As the global pandemic caused by the coronavirus SARS-CoV-2 continues, researchers are working at unprecedented speed to produce new treatments and vaccines. Much work has focused on studying antibodies from the blood of...
Biotech Penny Stocks Take Center Stage On Monday One industry has been more active than others this year. I think we can all consider biotech penny stocks among the sector stocks gaining ground in 2020. Much of that has stemmed from coronavirus vaccine development and testing options. Other ...
Are These On Your List Of Penny Stocks To Buy Or Sell Right Now? There are still plenty of penny stocks to watch right now. We’re heading into the final days of the month and small-cap stocks remain a focus. One of the things that I’ve continued to see are questions arising fro...
Ampio Pharmaceuticals (NYSEMKT: AMPE ) initiates dosing patients in Phase 1 U.S. based clinical trial evaluating a 5-day intravenous Ampion treatment for COVID-19 patients requiring supplemental oxygen. More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news,...
ENGLEWOOD, Colo. , July 23, 2020 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio"), is a biopharmaceutical company focused on the development and advancement of immunology-based therapies for prevalent inflammatory conditions. As part of thi...
ENGLEWOOD, Colo. , July 20, 2020 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the development and advancement of immunology based therapies for prevalent inflammatory conditions, today announced the publicati...
News, Short Squeeze, Breakout and More Instantly...
Ampio Pharmaceuticals Inc. Company Name:
AMPE Stock Symbol:
OTCMKTS Market:
Ampio Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Next.e.GO N.V. (EGOX) rose 94.4% to $0.07 on volume of 92,836,985 shares AGBA Group Holding Limited (AGBA) rose 46.1% to $1.505 on volume of 55,502,222 shares PROSHARES TRUST (SQQQ) rose 1.2% to $12.2099 on volume of 25,933,897 shares...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 7.2% to $0.04 on volume of 426,309,096 shares PROSHARES TRUST (SQQQ) rose 1.8% to $12.07 on volume of 171,048,374 shares AGBA Group Holding Limited (AGBA) rose 157.5% to $1.03 on volume of 121,894,6...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...